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cancer progression through transcriptional
repression of the tumor suppressor ARHI
Li-Liang Li1†, Ai-Min Xue1†, Bei-Xu Li1, Yi-Wen Shen1, Yu-Hua Li1, Cheng-Liang Luo1, Ming-Chang Zhang1,
Jie-Qing Jiang1, Zu-De Xu2, Jian-Hui Xie1* and Zi-Qin Zhao1*In the original publication of the article [1], we noticed
an error to Table 2. The numbers for each ARHI stain-
ing in the subtypes of JMJD2A were mistakenly copied
from another molecular which we were simultaneously
working on. This mistake went unfortunately unnoticed
in the thereafter review and proofreading processes.
The Table 2 shown in this erratum is the correct repre-
sentation of the data from this study. The authors
apologize for this error.
As a consequence, the sentence in the left column of
Page 6 of 14 of the article PDF, line 4-6, should be ac-
cordingly corrected to be “Spearman correlation analysis
showed that expression of JMJD2A was inversely corre-
lated with expression of ARHI (p = 0.021, r = -0.185,
Table 2)”.
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Table 2 Association between JMJD2A expression and
clinicopathological parameters in 155 cases of breast cancers










Negative 52 4 18 17 13 0.778 -0.023
positive 103 7 38 36 22
PR
Negative 77 7 22 26 22 0.147 -0.117
positive 78 4 34 27 13
HER2
Negative 7 0 3 2 2 0.742 -0.027
Positive 148 11 53 51 33
ARHI
Negative 63 3 18 23 19 0.021* -0.185
Positive 92 8 38 30 16
* p <0.05
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